KETAMINE HYDROCHLORIDE
Generic: KETAMINE HYDROCHLORIDE
Gland Pharma LimitedManufacturer
INTRAMUSCULAR, INTRAVENOUSRoute
KETAMINE HYDROCHLORIDEActive Substance
2023-01-24Original Approval
KETAMINE HYDROCHLORIDE is FDA application ANDA216809, sponsored by GLAND. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
INFUSION SITE PAIN
797 reports
2
DRUG INEFFECTIVE
527 reports
3
NAUSEA
518 reports
4
INFUSION SITE ERYTHEMA
501 reports
5
OFF LABEL USE
428 reports
6
INFUSION SITE SWELLING
347 reports
7
HEADACHE
335 reports
8
DIARRHOEA
312 reports
9
DYSPNOEA
300 reports
10
HYPERHIDROSIS
237 reports